2020
DOI: 10.1177/2324709620972244
|View full text |Cite
|
Sign up to set email alerts
|

An Acute Pulmonary Coccidioidomycosis Coinfection in a Patient Presenting With Multifocal Pneumonia With COVID-19

Abstract: The ongoing coronavirus disease-2019 (COVID-19) pandemic has been the focus of health care workers as it has affected millions of people and cost hundreds of thousands of lives around the world. As hospitals struggle to identify and care for those afflicted with COVID-19, it is easy to overlook endemic diseases that potentially worsen or mimic the pulmonary manifestations or may coinfect those with COVID-19. In this case report, we present the case of a 48-year-old Hispanic female who was admitted with respira… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
33
0
2

Year Published

2021
2021
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(35 citation statements)
references
References 5 publications
0
33
0
2
Order By: Relevance
“… 1 We posit that his initially subclinical infection was worsened by SARS-CoV-2-mediated immunosuppression. Although Coccidioides infection has been described during the management of COVID-19 before, 16 it is recognized that our patient may have had two unrelated primary infectious processes occurring simultaneously. This is improbable: coccidioidomycosis is not a contagious disease between humans, and Coccidioides is not endemic in Guam, with his only potential location for infection having been in California before deployment.…”
Section: Discussionmentioning
confidence: 78%
“… 1 We posit that his initially subclinical infection was worsened by SARS-CoV-2-mediated immunosuppression. Although Coccidioides infection has been described during the management of COVID-19 before, 16 it is recognized that our patient may have had two unrelated primary infectious processes occurring simultaneously. This is improbable: coccidioidomycosis is not a contagious disease between humans, and Coccidioides is not endemic in Guam, with his only potential location for infection having been in California before deployment.…”
Section: Discussionmentioning
confidence: 78%
“…Because SARS-CoV-2 and treatments such as dexamethasone or tocilizumab can impair the immune system, some researchers anticipated the possibility of fungal superinfection among COVID-19 patients ( 3 – 6 ). As of August 2020, researchers have documented COVID-19–associated pulmonary aspergillosis (CAPA) ( 7 – 9 ), invasive candidiasis ( 10 ), coccidioidomycosis ( 11 ), fusariosis ( 12 ), histoplasmosis ( 13 ), mucormycosis ( 14 ), pneumocystosis ( 15 ), and saccharomycosis ( 16 ). Varying cumulative rates of CAPA have been described, including rates of 0.7%–7.7% among COVID-19 patients ( 17 , 18 ), 2.5%–39.1% among ICU patients with COVID-19 ( 19 , 20 ), and 3.2%–29.6% among COVID-19 patients on mechanical ventilation ( 7 , 17 ).…”
mentioning
confidence: 99%
“…Information on endemic fungal co-infections with SARS-CoV-2 is scarce. Only five cases have been published so far, two of COVID-19 and coccidioidomycosis in California, United States [ 102 , 103 ], and three of COVID-19 and histoplasmosis in Rio Grande, Southern Brazil, and Buenos Aires, Argentina [ 104 , 105 , 106 ] ( Table 5 ). Coccidioidomycosis co-infections were caused by C. immitis [ 102 , 103 ].…”
Section: Endemic Mycoses and Covid-19mentioning
confidence: 99%
“…Only five cases have been published so far, two of COVID-19 and coccidioidomycosis in California, United States [ 102 , 103 ], and three of COVID-19 and histoplasmosis in Rio Grande, Southern Brazil, and Buenos Aires, Argentina [ 104 , 105 , 106 ] ( Table 5 ). Coccidioidomycosis co-infections were caused by C. immitis [ 102 , 103 ]. They occurred in a man and a woman, both 48 years of age, with the main predisposing factor of residing in endemic areas [ 102 , 103 ].…”
Section: Endemic Mycoses and Covid-19mentioning
confidence: 99%
See 1 more Smart Citation